Sumitomo Pharma CoTSE:4506 -3.31%56 FCF Margin % is 26.52% as of Mar. 2026, which is 433% above its 10-year median of 4.98. GuruFocus rates TSE:4506 with a GF Score™ of 56/100 and a GF Value™ of 円827.78 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, Sumitomo Pharma Co ranks better than 79.65% on this metric.
The historical rank and industry rank for Sumitomo Pharma Co's FCF Margin % or its related term are showing as below:
TSE:4506'
s FCF Margin % Range Over the Past 10 Years
Min: -81.9 Med: 4.98 Max: 24.19
Current: 14.21
During the past 13 years, the highest FCF Margin % of Sumitomo Pharma Co was 24.19%. The lowest was -81.90%. And the median was 4.98%.
TSE:4506's FCF Margin % is ranked better than 79.65% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs TSE:4506: 14.21
Sumitomo Pharma Co FCF Margin % Related Terms
Sumitomo Pharma Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Sumitomo Pharma Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sumitomo Pharma Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sumitomo Pharma Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sumitomo Pharma Co (TSE:4506) has a FCF Margin % of 26.52% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sumitomo Pharma Co and its competitors. This is 433% above median its historical median of 4.98. According to the industry distribution chart, Sumitomo Pharma Co ranks #195 out of 958 companies in the Drug Manufacturers industry, placing it in the top 20.4%.
Is Sumitomo Pharma Co's FCF Margin % too high?
Sumitomo Pharma Co's current FCF Margin % of 26.52% is 433% above median its 10-year median of 4.98. The Drug Manufacturers industry median FCF Margin % is 2.45. Sumitomo Pharma Co's value of 26.52% is 984.7% above this industry median. Based on the distribution chart, Sumitomo Pharma Co ranks #195 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sumitomo Pharma Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sumitomo Pharma Co's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sumitomo Pharma Co ranks #195 out of 958 companies for FCF Margin %. This places Sumitomo Pharma Co in the top 20% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. Sumitomo Pharma Co's value of 26.52% is 984.7% above this benchmark. While the company's 10-year median is 4.98 vs. the industry median of 2.45, Sumitomo Pharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sumitomo Pharma Co's current FCF Margin % of 26.52% is 984.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sumitomo Pharma Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sumitomo Pharma Co's current FCF Margin % is 26.52%, which is 433% above median its own 10-year median of 4.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sumitomo Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Sumitomo Pharma Co (TSE:4506) is currently considered Significantly Overvalued. The stock's GF Value™ is 円827.78, compared to a current price of 円1,444.00 — trading 74.4% above its estimated fair value. The current FCF Margin % is 26.52%, which is 433% above median its 10-year median of 4.98 and 984.7% above the Drug Manufacturers industry median of 2.45. Sumitomo Pharma Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sumitomo Pharma Co (TSE:4506), the current FCF Margin % is 26.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sumitomo Pharma Co (TSE:4506) Overvalued in 2026?
Based on GuruFocus' analysis, Sumitomo Pharma Co stock appears to be overvalued.
The current stock price of 円1,444.00 is trading 74.4% above its estimated GF Value™ of 円827.78.
GuruFocus considers Sumitomo Pharma Co to be Significantly Overvalued.
Key valuation signals for TSE:4506:
FCF Margin %: 26.52% (433% above median its 10-year median of 4.98)
GF Value™: 円827.78 vs. price of 円1,444.00 (74.4% above fair value)
Industry Position: 984.7% above the Drug Manufacturers median (#195 of 958)
No single metric tells the full story. See the TSE:4506 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
56GF Score
Get the complete analysis for TSE:4506
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4506 has been successfully added to your 
